Navigation Links
Enduring anti-clotting treatment avails heart patients

According to a new study, researchers have observed that patients who took aspirin and anti-clotting drugs for a year after angioplasty had a decreased risk of problems. Angioplasty involves inserting a balloon and then a device called a stent into a blocked coronary artery.// It's often life-saving, for it opens up the artery again. However, one complication that often occurs when such percutaneous coronary interventions (PCIs) take place is clotting.

Previous research has shown the advantage of tackling the clotting problem with aspirin and anti-clotting drugs given for a few weeks after the PCI. A new study now shows that giving the combination therapy for a whole year gives even better results.

Researchers at the University of North Carolina studied a group of over 1,500 patients receiving either the anti-clotting drug clopidogrel or placebo for a year after PCI. All of them also received aspirin. At the end of the study, there were significantly fewer adverse events, such as heart attack, clotting or need for further intervention, in the clopidogrel group. Researchers feel that what was less clear was the benefit of giving the drug before PCI as well - but it seems likely that this will help at least some patients.


'"/>




Page: 1

Related medicine news :

1. Bivalirudin, a new anti-clotting drug may be a safer option for treatment of acute coronary conditions
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Feeding channel created by malaria parasite - a new target for malaria treatments
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... If you don’t mind a bit of prickly ... may want to consider a treatment that some have called the next great tool ... , Microneedling, also known as skin needling, is a procedure using a device covered ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Medical Society of Northern Virginia, Announces DoctorsTelemed?, A telehealth solution powered ... of Northern Virginia (MSNVA) launches DoctorsTelemed?, a telemedicine solution that uses CloudVisit’s ...
(Date:5/5/2016)... ... May 05, 2016 , ... Augusta Public Schools has teamed with ... partnership will enable school health offices to streamline and bolster care for district students. ... east of Wichita. Augusta public schools serve 2,300 students among its six schools. ...
(Date:5/5/2016)... ... 2016 , ... The Wisconsin Independent Private Practice Alliance (WIPPA/aka ... WCS, has been selected by the Wisconsin Physical Therapy Association (WPTA) as this ... is awarded annually to a member of the WPTA to recognize a Wisconsin ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... patented products, announces the Everlasting Glove, a sports invention that aids in the ... Sporting Goods Manufacturing industry is worth $9 billion," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Myeloma Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Multiple ... Myeloma market valuations and forecast, Multiple Myeloma ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute lymphocytic Leukemia Market ... to their offering.       (Logo: ... Acute Lymphocytic Leukemia Market and Competitive Landscape ... Lymphocytic Leukemia pipeline products, Acute Lymphocytic Leukemia ...
(Date:5/3/2016)... -- Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling ... ... ... ... ...
Breaking Medicine Technology: